The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMurray International Regulatory News (MYI)

Share Price Information for Murray International (MYI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 253.50
Bid: 252.00
Ask: 252.50
Change: 0.00 (0.00%)
Spread: 0.50 (0.198%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 253.50
MYI Live PriceLast checked at -
Murray International is an Investment Trust

To achieve an above average dividend yield, with long term growth in dividends and capital ahead of inflation, by investing principally in global equities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

26 Apr 2018 12:30

RNS Number : 2579M
Murray International Trust PLC
26 April 2018
 

MURRAY INTERNATIONAL TRUST PLC (the "Company")

Legal Entity Identifier (LEI): 549300BP77JO5Y8LM553

 

26 April 2018

 

Appointment of New Director

 

The Board of Murray International Trust PLC is pleased to announce the appointment of Ms Claire Binyon as an independent non-executive Director of the Company with effect from 1 May 2018.

 

Dr Kevin Carter, Chairman, commented on the appointment:

 

"I would like to welcome Claire to the Board. Claire is a chartered accountant who, following an early career in corporate finance in the City, has embarked on a successful career working for global multinationals in areas of corporate development, strategic planning and finance. Claire is currently group corporate development director at Fenner PLC having previously served as head of strategy and corporate development at DS Smith Plc following similar roles in other multinational companies including Cadbury plc and InBev S.A. Claire brings significant corporate and strategic knowledge and perspective to the Board."

 

There are no other disclosures required to be made for Ms Binyon in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Ms Binyon does not hold any interests in any of the Company's shares.

 

Directorate

 

The Company confirms that, as indicated in the Annual Report and financial statements, Mr Jim Best is retiring as a Director of the Company with effect from the conclusion of the Annual General Meeting ("AGM") today. The Directors would like to reiterate their thanks and appreciation for the contribution made by Mr Best as a Director and latterly as Senior Independent Director of the Company. Mr Peter Dunscombe will become Senior Independent Director with effect from the close of business at today's AGM.

 

 

Aberdeen Asset Management PLC

Company Secretary

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOABBGDSGBDBGIL
Date   Source Headline
21st Aug 20231:38 pmRNSGearing disclosure
21st Aug 202312:56 pmRNSNet Asset Value(s)
18th Aug 20235:15 pmRNSTransaction in Own Shares
18th Aug 20231:08 pmRNSNet Asset Value(s)
17th Aug 20231:03 pmRNSNet Asset Value(s)
16th Aug 202311:30 amRNSNet Asset Value(s)
15th Aug 202311:16 amRNSNet Asset Value(s)
14th Aug 20235:12 pmRNSTransaction in Own Shares
14th Aug 20233:14 pmRNSGearing disclosure
14th Aug 202312:24 pmRNSNet Asset Value(s)
11th Aug 202312:51 pmRNSNet Asset Value(s)
11th Aug 20237:00 amRNSHalf-year Report
10th Aug 20234:40 pmRNSPortfolio Disclosures
10th Aug 20231:26 pmRNSNet Asset Value(s)
9th Aug 20235:16 pmRNSTransaction in Own Shares
9th Aug 20231:20 pmRNSNet Asset Value(s)
8th Aug 20235:25 pmRNSTransaction in Own Shares
8th Aug 202311:54 amRNSNet Asset Value(s)
7th Aug 20235:21 pmRNSTransaction in Own Shares
7th Aug 20232:52 pmRNSGearing Disclosures
7th Aug 202312:53 pmRNSNet Asset Value(s)
4th Aug 20235:18 pmRNSTransaction in Own Shares
4th Aug 20234:24 pmRNSMonth End Net Asset Value(s)
4th Aug 20232:37 pmRNSSecond Interim Dividend
4th Aug 202312:01 pmRNSNet Asset Value(s)
3rd Aug 20235:21 pmRNSTransaction in Own Shares
3rd Aug 202312:47 pmRNSNet Asset Value(s)
2nd Aug 20235:19 pmRNSTransaction in Own Shares
2nd Aug 202312:41 pmRNSNet Asset Value(s)
1st Aug 20235:13 pmRNSTransaction in Own Shares
1st Aug 202310:30 amRNSTotal Voting Rights
31st Jul 20234:44 pmRNSGearing disclosure
31st Jul 202312:39 pmRNSNet Asset Value(s)
28th Jul 202312:23 pmRNSNet Asset Value(s)
27th Jul 202311:50 amRNSNet Asset Value(s)
26th Jul 202311:31 amRNSNet Asset Value(s)
25th Jul 20235:19 pmRNSTransaction in Own Shares
25th Jul 20235:05 pmRNSBlock listing Interim Review
25th Jul 202311:44 amRNSNet Asset Value(s)
24th Jul 20235:15 pmRNSTransaction in Own Shares
24th Jul 20232:50 pmRNSGearing disclosure
24th Jul 202311:31 amRNSNet Asset Value(s)
21st Jul 20235:16 pmRNSTransaction in Own Shares
21st Jul 202311:42 amRNSNet Asset Value(s)
20th Jul 202312:37 pmRNSNet Asset Value(s)
19th Jul 202312:13 pmRNSNet Asset Value(s)
18th Jul 20235:37 pmRNSTransaction in Own Shares
18th Jul 202311:45 amRNSNet Asset Value(s)
17th Jul 20231:14 pmRNSGearing disclosure
17th Jul 202312:01 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.